glp 1 agonists and sglt2 inhibitors Complementary Yet Distinct Roles of GLP-1 Receptor in Cardiovascular Risk Reduction Use of GLP-1 Receptor Agonists

Setting realistic expectations is crucial: weight loss is gradual, with clinical trials showing approximately 15% weight reduction with semaglutide 2.4 mg at 68 weeks and up to 21% with tirzepatide at 72 weeks, though individual responses vary considerably

Abbreviations PsO: Psoriasis IMQ: Imiquimod PUVA: Psoralen + Ultraviolet A HaCaT: Human adult low calcium high temperature (immortalized keratinocyte cell line) PASI: Psoriasis area and severity index NF-B: Nuclear Factor kappa-light-chain-enhancer of activated B cells JAK: Janus kinase STAT: Signal transducer and activator of transcription STAT3: Signal transducer and activator of transcription 3 IL: Interleukin TNF-: Tumor necrosis factor-alpha TNF: Tumor necrosis factor IFN-: Interferon-gamma EGCG: Epigallocatechin gallate ROS: Reactive oxygen species Nrf2: Nuclear factor erythroid 2related factor 2 UV: Ultraviolet BALB/c: Mouse strain EE: Entrapment efficiency NLC: Nanostructured lipid carrier SLN: Solid lipid nanoparticles PVA: Polyvinyl alcohol MS: Multiple sclerosis AA: Arachidonic acid SK: Skin MA: Methacrylic acid SA: Stearic acid References Morrone A, DellAnna ML, Cristaudo A, Wubayehu T, Godefay H, Barnabas GA, et al

Impact of obesity on remission and disease activity in rheumatoid arthritis: a systematic review and meta-analysis

Chen, L.T

10.1210/mend.11.13.0032 69